SANTA ANA, Calif.--(BUSINESS WIRE)--Advanced Medical Optics, Inc. (AMO) (NYSE:EYE), a global leader in ophthalmic surgical devices and eye care products, today announced that Chairman, President and CEO Jim Mazzo has amended his stock trading plan, which was implemented in 2005 under AMO’s stock trading program in accordance with Rule 10b5-1 of the Securities and Exchange Act of 1934. The program permits participating company executives and board members to adopt pre-arranged plans to buy or sell pre-determined amounts of AMO stock over time in compliance with AMO’s insider trading policies and stock ownership guidelines.
